Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Discovery of novel protein could lead to potential new treatments for age-related retinal disease

The discovery of a novel protein that links aging and age-dependent retinal diseases could lead to potential new treatments for conditions that cause sight loss in later life.

15 Nov 2016

TSRI study suggests new approach to limit tumor growth by targeting immune system cells

A new study led by scientists at The Scripps Research Institute suggests there may be a way to limit tumor growth by targeting immune system cells called macrophages.

11 Nov 2016

Ophthalmologists focus on dim-light driving situations that can endanger drivers and pedestrians

As the end of daylight saving time draws near, ophthalmologists at the Vanderbilt Eye Institute want to focus on a real issue — dim-light driving situations that can endanger drivers and pedestrians.

8 Nov 2016

Researchers map two gene mutations that trigger retinal disease leading to macular degeneration

Two gene mutations that trigger a retinal disease that causes blindness in one in 5,000 males have been mapped, leading to the potential for new therapeutic treatments.

7 Nov 2016

Second Sight successfully implants wireless multichannel neurostimulation system in human subject

Second Sight Medical Products, Inc. (Second Sight or the Company), a developer, manufacturer and marketer of implantable visual prosthetics to restore functional vision to blind patients, today announced the first successful implantation and activation of a wireless visual cortical stimulator in a human subject, providing the initial human proof of concept for the ongoing development of the Company's Orion™ I Visual Cortical Prosthesis (Orion I).

1 Nov 2016

Clinical study results reveal long-term safety of gene transfer to treat macular degeneration

The long-term safety of gene transfer to treat neovascular age-related macular degeneration (NVAMD), and the production of two therapeutic proteins encoded by those genes for at least 2.5 years in the eyes of patients with advanced NVAMD are demonstrated in the results of a clinical trial published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

20 Oct 2016

Novel methods may be effective in treating people with presbyopia

Researchers are testing cutting-edge treatments for people who want to see up close without reading glasses and finding promising results, according to studies presented this week at AAO 2016, the 120th annual meeting of the American Academy of Ophthalmology.

18 Oct 2016

Healthy fruit-rich Mediterranean diet may help protect against macular degeneration

People who closely follow the Mediterranean diet - -especially by eating fruit -- may be more than a third less likely to develop age-related macular degeneration, a leading cause of blindness, according to a study presented today at AAO 2016, the 120th annual meeting of the American Academy of Ophthalmology.

17 Oct 2016

Encapsulated cell therapy could be new way to fight glaucoma

An experimental drug, consisting of cells manufactured and implanted in the eye to stimulate optic nerve growth and activity, could be an entirely new way of fighting glaucoma, according to BrightFocus Foundation.

14 Oct 2016

Vula Mobile awarded inaugural Clearly Vision Prize for helping tackle global problem of poor vision

A revolutionary app connecting primary healthcare workers in remote areas with on-call specialists has been awarded the inaugural Clearly Vision Prize, a competition to accelerate the ventures tackling the number one unaddressed disability in the world – poor vision.

14 Oct 2016

UEF research shows retinal changes may be detected earlier than brain changes

Diseases of the central nervous system (CNS) may manifest as pathological changes in the retina of the eye.

3 Oct 2016

Research findings offer promising treatment target for blinding diseases

New research published in Cell Reports identifies a potential treatment target for blinding diseases such as retinitis pigmentosa and advanced dry age-related macular degeneration.

28 Sep 2016

Six NIH-funded projects aim to identify biological factors that affect neural regeneration

The National Institutes of Health will fund six projects to identify biological factors that affect neural regeneration in the retina.

2 Sep 2016

Gentle combination of FDA-approved drugs could combat photoreceptor degeneration in mice

In microseconds, every light ray that enters the eye triggers an explosion of coordinated cellular events.

29 Aug 2016

RPB continues research initiative to address urgent needs in treating low vision

Research to Prevent Blindness is continuing its research initiative to address urgent needs in understanding and treating low vision.

28 Aug 2016

Research opens way towards making promising advances in retinal prostheses

A major therapeutic challenge, the retinal prostheses that have been under development during the past ten years can enable some blind subjects to perceive light signals, but the image thus restored is still far from being clear.

25 Aug 2016

UA experts offer advice on choosing right pair of sunglasses

Experts from the University of Alicante have found that prolonged exposure to the sun increases the chance of developing alterations in the lens by 4%. Choosing the right pair of sunglasses can reduce such complications.

9 Aug 2016

Combinations of FDA-approved drugs may prevent vision loss linked to retinal degeneration

Combinations of Food and Drug Administration-approved drugs protect against the loss of cells required for vision in a mouse model of blinding retinal diseases.

4 Aug 2016

Researchers find potential way for delivering gene therapy to treat eye diseases

Eye diseases such as diabetic retinopathy and age-related macular degeneration are among the leading causes of irreversible vision loss and blindness worldwide. Currently, gene therapy can be administered to treat these conditions -- but this requires an injection.

27 Jul 2016

Clinical trial to assess safety of using umbilical cord cells to treat macular degeneration

UIC is part of a national phase 2 clinical trial to evaluate the safety and tolerability of using cells derived from multipotent umbilical cord cells to treat age-related macular degeneration, the most common cause of vision loss in people over 55.

21 Jul 2016

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Discovery of novel protein could lead to potential new treatments for age-related retinal disease

TSRI study suggests new approach to limit tumor growth by targeting immune system cells

Ophthalmologists focus on dim-light driving situations that can endanger drivers and pedestrians

Researchers map two gene mutations that trigger retinal disease leading to macular degeneration

Second Sight successfully implants wireless multichannel neurostimulation system in human subject

Clinical study results reveal long-term safety of gene transfer to treat macular degeneration

Novel methods may be effective in treating people with presbyopia

Healthy fruit-rich Mediterranean diet may help protect against macular degeneration

Encapsulated cell therapy could be new way to fight glaucoma

Vula Mobile awarded inaugural Clearly Vision Prize for helping tackle global problem of poor vision

UEF research shows retinal changes may be detected earlier than brain changes

Research findings offer promising treatment target for blinding diseases

Six NIH-funded projects aim to identify biological factors that affect neural regeneration

Gentle combination of FDA-approved drugs could combat photoreceptor degeneration in mice

RPB continues research initiative to address urgent needs in treating low vision

Research opens way towards making promising advances in retinal prostheses

UA experts offer advice on choosing right pair of sunglasses

Combinations of FDA-approved drugs may prevent vision loss linked to retinal degeneration

Researchers find potential way for delivering gene therapy to treat eye diseases

Clinical trial to assess safety of using umbilical cord cells to treat macular degeneration

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in